ZAAL, Afra, Ronald P. ZWEEMER, Michal ZIKÁN, Ladislav DUŠEK, Denid QUERLEU, Fabrice LÉCURU, Anne Sophie BATS, Robert JACH, Libor SEVCIK, Petar GRAF, Jaroslav KLAT, Grzegorz DYDUCH, Silvia von MENSDORFF-POULLY, Gemma G. KENTER, René H.M. VERHEIJEN and David CIBULA. Pelvic lymphadenectomy improves survival in patients with cervical cancer with low-volume disease in the sentinel node: A retrospective multicenter cohort study. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2014, vol. 24, No 2, p. 303-311. ISSN 1048-891X. Available from: https://dx.doi.org/10.1097/IGC.0000000000000043.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Pelvic lymphadenectomy improves survival in patients with cervical cancer with low-volume disease in the sentinel node: A retrospective multicenter cohort study
Authors ZAAL, Afra (528 Netherlands), Ronald P. ZWEEMER (528 Netherlands), Michal ZIKÁN (203 Czech Republic), Ladislav DUŠEK (203 Czech Republic, guarantor, belonging to the institution), Denid QUERLEU (250 France), Fabrice LÉCURU (250 France), Anne Sophie BATS (250 France), Robert JACH (616 Poland), Libor SEVCIK (203 Czech Republic), Petar GRAF (203 Czech Republic), Jaroslav KLAT (203 Czech Republic), Grzegorz DYDUCH (616 Poland), Silvia von MENSDORFF-POULLY (528 Netherlands), Gemma G. KENTER (528 Netherlands), René H.M. VERHEIJEN (528 Netherlands) and David CIBULA (203 Czech Republic).
Edition INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, PHILADELPHIA, LIPPINCOTT WILLIAMS & WILKINS, 2014, 1048-891X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.958
RIV identification code RIV/00216224:14110/14:00075682
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1097/IGC.0000000000000043
UT WoS 000336489200020
Keywords in English Isolated tumor cells; Low-volume disease; Lymph node dissection; Lymph node metastasis; Micrometastasis; Sentinel lymph node; Survival; Uterine cervical cancer
Tags EL OK
Tags Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 24/4/2015 13:05.
Abstract
Objective: In this study, we aimed to describe the value of pelvic lymph node dissection (LND) after sentinel lymph node (SN) biopsy in early-stage cervical cancer. Methods: We performed a retrospective multicenter cohort study in 8 gynecological oncology departments. In total, 645 women with International Federation of Gynecology and Obstetrics stage IA to IIB cervical cancer of squamous, adeno, or adenosquamous histologic type who underwent SN biopsy followed by pelvic LND were enrolled in this study. Radioisotope tracers and blue dyewere used to localize the sentinel node, and pathologic ultrastaging was performed. Results: Among the patients with low-volume disease (micrometastases and isolated tumor cells) in the sentinel node, the overall survivalwas significantly better (P = 0.046) ifmore than 16 non-SNs were removed. No such significant difference in survivalwas detected in patients with negative or macrometastatic sentinel nodes. Conclusions: Our findings indicate that in patients with negative or macrometastatic disease in the sentinel nodes, an additional LND did not alter survival. Conversely, our data suggest that the survival of patients with low-volume disease is improved when more than 16 additional lymph nodes are removed. If in a prospective trial our data are confirmed, we would suggest a 2-stage operation.
PrintDisplayed: 24/5/2024 04:53